Sirius XM Holdings Inc. (NASDAQ:SIRI)

Sirius XM Holdings Inc. is a radio broadcasting company. It creates and broadcasts commercial-free music; premier sports and live events; news and comedy; exclusive talk and entertainment; and the most comprehensive lineup of Latin commercial-free music, sports, and talk programming in radio. SiriusXM content is available via satellite and through the SiriusXM Internet Radio app for smartphones and other connected devices, as well as online at siriusxm.com. Sirius XM Holdings Inc., formerly known as Sirius XM Radio Inc., is headquartered in New York.

Sirius XM Holdings Inc. (NASDAQ:SIRI)’s Financial Overview

Sirius XM Holdings Inc. (NASDAQ:SIRI) declined -0.87% yesterday to close its trading session at $4.57. The company has 1 year Price Target of $4.89. Sirius XM Holdings Inc. has 52-Week high of $4.65 and 52-Week Low of $3.29. The stock touched its 52-Week High on Nov 30, 2016 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 31.36 Million shares yesterday. The firm shows the market capitalization of $22.05 Billion.

Sirius XM Holdings Inc. (NASDAQ:SIRI) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.04/share against the analyst consensus estimate of $0.04/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.

The firm is trading with SMA20 of 3.59 Percent, SMA50 of 7.54 Percent and SMA200 of 12.74 percent. Sirius XM Holdings Inc. has P/S value of 4.49 while its P/B value stands at 0. Similarly, the company has Return on Assets of 8.8 percent, Return on Equity of -141.7 percent and Return on Investment of 15.1 Percent. The company shows Gross Margin and Operating Margin of 61.1 percent and 29.5 percent respectively.

Many brokerage firms are involved in issuing their ratings on Sirius XM Holdings Inc. (NASDAQ:SIRI). On 12-Jul-16 Telsey Advisory Group Initiated Sirius XM Holdings Inc. Stock  to Market Perform. Another firm also rated the stock on 18-Sep-15 where Gabelli & Co Initiated the stock to Buy.

The Stock currently has Analyst’ mean Recommendation of 2.2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 15 analysts offering 12-month price forecasts for Sirius XM Holdings Inc have a median target of 4.85, with a high estimate of 5.55 and a low estimate of 4.50. The median estimate represents a +6.13% increase from the last price of 4.57.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Seattle Genetics, Inc. (NASDAQ:SGEN)

Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company’s lead product, ADCETRIS® (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.

Seattle Genetics, Inc. (NASDAQ:SGEN)’s Financial Outlook

The 15 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 51.00, with a high estimate of 72.00 and a low estimate of 42.00. The median estimate represents a -21.31% decrease from the last price of 64.81.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Seattle Genetics, Inc. has a Consensus Recommendation of 2.13. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -2.37% and closed its last trading session at $64.81. The company has the market capitalization of $9.17 Billion. The stock has 52-week high of $75.36 and 52-Week low of $26.02. The firm touched its 52-Week high on Nov 10, 2016 and 52-Week low on Feb 10, 2016. The company has volume of 5.54 Million shares. The company has a total of 141.55 Million shares outstanding.

Seattle Genetics, Inc. (NASDAQ:SGEN) in the last quarter reported its actual EPS of $-0.23/share where the analyst estimated EPS was $-0.29/share. The difference between the actual and Estimated EPS is $0.06. This shows a surprise factor of 20.7 percent.

The company has YTD performance of 44.41 percent. Beta for Seattle Genetics, Inc. stands at 2.35 while its ATR (average true range) is 3.34. The company has Weekly Volatility of 4.43%% and Monthly Volatility of 5.81%%.

Seattle Genetics, Inc. has distance from 20-day Simple Moving Average (SMA20) of -2.07%, Distance from 50-Day Simple Moving Average of 10.89 percent and Distance from 200-Day Simple Moving Average of 45.6%.

The Company currently has ROA (Return on Assets) of -12.6 percent, Return on Equity (ROE) of -16.3 Percent and Return on Investment (ROI) of -17.6% with Gross margin of 89.9 percent and Operating & Profit margin of -27.6% and -27% respectively.